Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neurocrine Bioscience buy Deutsche Bank Aktiengesellschaft

Start price
€111.60
12.12.23 / 50%
Target price
€126.18
12.12.24
Performance (%)
13.84%
Price
€127.05
26.04.24
Summary
This prediction is currently active. The BUY prediction by Deutsche_Bank_Aktien currently has a performance of 13.84%. This prediction currently runs until 12.12.24. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Neurocrine Bioscience 2.542% 2.542%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by Deutsche_Bank_Aktien for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) 13.84%
Target price 126.181
Change
Ends at 12.12.24

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat